Michelle Green, PA
Physician Assistant · Tulsa, OKNPI 1043754641
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Dexcom, Inc. at 53.5% of the total. 2025 is the largest year on record at $11,701, more than ten times the $36 reported in 2021. Among physician assistant clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 435 payments — averaging $40.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$9K
- Abbott$1K
- Lilly USA, LLC$1K
- Boehringer Ingelheim$681
- Bayer$659
- Novo Nordisk$646
- plus $4K from 29 others
What the payments were for
- Speaking & faculty fees$7,77044%
- Travel & lodging$7604%
- Food & beverage$9,06951%
- Other$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 61 | $9,449 |
| Abbott | 49 | $1,356 |
| Lilly USA, LLC | 50 | $1,082 |
| Boehringer Ingelheim | 31 | $681 |
| Bayer | 30 | $659 |
| Novo Nordisk | 46 | $646 |
| Insulet Corporation | 12 | $443 |
| Medtronic | 5 | $317 |
| Esperion Therapeutics, Inc. | 11 | $316 |
| Corcept Therapeutics | 19 | $299 |
| Amgen | 20 | $290 |
| Mannkind Corporation | 13 | $264 |
| Novartis | 13 | $237 |
| Xeris Pharmaceuticals, Inc. | 12 | $225 |
| Amneal Pharmaceuticals LLC | 10 | $197 |
| AbbVie | 10 | $165 |
| Pharmacosmos Therapeutics Inc. | 1 | $123 |
| Inari Medical, Inc. | 1 | $104 |
| Currax Pharmaceuticals LLC | 6 | $88 |
| Recordati_rare_diseases_inc. | 3 | $74 |
| Tandem Diabetes Care, Inc. | 3 | $73 |
| Kyowa Kirin, Inc. | 3 | $69 |
| BETA Bionics, Inc. | 3 | $68 |
| Intra-sana Laboratories | 4 | $66 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| AstraZeneca(2 entities) | 4 | $61 |
| Antares Pharma, Inc. | 3 | $54 |
| Biohaven Pharmaceuticals, Inc. | 1 | $36 |
| Astellas Pharma US Inc | 1 | $34 |
| Rhythm Pharmaceuticals, Inc. | 1 | $31 |
| Sequel Med Tech, LLC | 1 | $23 |
| Philips North America LLC | 1 | $15 |
| Ascendis Pharma Endocrinology Inc | 1 | $15 |
| Halozyme Inc | 1 | $14 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$8,792
- DEXCOM STELO GLUCOSE BIOSENSOR$8,792
- FREESTYLE LIBRE 3$457
- JARDIANCE$341
- SIMPLERA SENSOR$155
- Monoferric$123
- NEXLIZET$119
- NEXLETOL$119
- AFREZZA$115
- MINIMED 780G$110
- Kerendia$109
- ZEPBOUND$109
- Omnipod$108
- FLOWTRIEVER CATHETER, S$104
- CT THROMBECTOMY SYSTEM KIT$104
How this compares
$17,649 in reported general payments places this provider in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 452 | $562,489 |
| OzempicSemaglutide | 335 | $454,773 |
| KorlymMifepristone | 11 | $436,068 |
| JardianceEmpagliflozin | 211 | $281,814 |
| Tresiba Flextouch U-200Insulin Degludec | 102 | $114,507 |
| TrulicityDulaglutide | 63 | $101,928 |
| FarxigaDapagliflozin Propanediol | 91 | $85,493 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 70 | $79,638 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 44 | $69,049 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 56 | $64,941 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 34 | $41,238 |
| JanuviaSitagliptin Phosphate | 38 | $40,311 |
| OmnitropeSomatropin | 20 | $30,527 |
| Tresiba Flextouch U-100Insulin Degludec | 42 | $30,139 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $27,131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $1,082 | $672,809564 claims |
| Novo NordiskOzempic, Novolog | $646 | $463,672365 claims |
| Corcept TherapeuticsKorlym | $299 | $436,06811 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $681 | $350,863255 claims |
| AstraZenecaFarxiga | $61 | $85,49391 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $62 | $79,63870 claims |
| BayerKerendia | $659 | $21,93812 claims |
| Esperion Therapeutics, Inc.Nexlizet | $316 | $17,44024 claims |
| AbbVieSynthroid | $165 | $14,059179 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $197 | $5,087506 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Tulsa
- Matthew PattonTulsa$24K
- Muge ParkTulsa$17K
- Rose RamirezTulsa$15K
- Melissa RohrerTulsa$14K
- Jenny BirksTulsa$13K
- Andrea BellassaiTulsa$12K
- Jennifer ComptonTulsa$12K
- Adrian DonnellyTulsa$12K
- Valerie TerrellTulsa$12K
- Lori RuleTulsa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.